{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:35:15Z","timestamp":1784010915116,"version":"3.55.0"},"reference-count":44,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Gastrointestinal (GI) bleeding is an important cause of morbidity and mortality in von Willebrand disease (VWD). It has been noted that GI bleeding caused by angiodysplasia is overrepresented in VWD patients compared to other causes. The bleeding from angiodysplasia is notoriously difficult to treat; recurrences and rebleeds are common. A growing body of basic science evidence demonstrates that von Willebrand factor negatively regulates angiogenesis through multiple pathways. VWD is clinically highly associated with angiodysplasia. The predisposition to angiodysplasia likely accounts for many of the clinical difficulties related to managing GI bleeding in VWD patients. Diagnosis and treatment are challenging with the current tools available, and much further research is needed to further optimize care for these patients with regard to acute treatment, prophylaxis, and adjunctive therapies. In this review we provide an overview of the available literature on GI bleeding in VWD and explore the molecular underpinnings of angiodysplasia-related GI bleeding. Considerations for diagnostic effectiveness are discussed, as well as the natural history and recurrence of these lesions and which therapeutic options are available for acute and prophylactic management.<\/jats:p>","DOI":"10.1182\/hematology.2022000390","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T16:14:20Z","timestamp":1670602460000},"page":"624-630","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":13,"title":["Special considerations in GI bleeding in VWD patients"],"prefix":"10.1182","volume":"2022","author":[{"given":"Nicholas L.J.","family":"Chornenki","sequence":"first","affiliation":[{"name":"Department of Medicine, Queen's University, Kingston, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Ocran","sequence":"additional","affiliation":[{"name":"Department of Medicine, Queen's University, Kingston, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula D.","family":"James","sequence":"additional","affiliation":[{"name":"Department of Medicine, Queen's University, Kingston, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"issue":"21","key":"2022120916103203500_hem2022000390C1","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1182\/blood-2008-10-165621","article-title":"von Willebrand factor to the rescue","volume":"113","author":"De Meyer","year":"2009","journal-title":"Blood"},{"issue":"1","key":"2022120916103203500_hem2022000390C2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","article-title":"The prevalence of symptomatic von Willebrand disease in primary care practice","volume":"8","author":"Bowman","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2022120916103203500_hem2022000390C3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"Connell","year":"2021","journal-title":"Blood Adv"},{"issue":"11","key":"2022120916103203500_hem2022000390C4","first-page":"1261","article-title":"Diagnosis and management of von Willebrand disease: guidelines for primary care","volume":"80","author":"Yawn","year":"2009","journal-title":"Am Fam Physician"},{"issue":"10","key":"2022120916103203500_hem2022000390C5","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2022120916103203500_hem2022000390C6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/MBC.0000000000000257","article-title":"Changes in bleeding patterns in von Willebrand disease after institution of long-term replacement therapy: results from the von Willebrand Disease Prophylaxis Network","volume":"26","author":"Holm","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"2022120916103203500_hem2022000390C7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2516.2008.01901.x","article-title":"Treatment and prevention of acute bleedings in von Willebrand disease\u2014efficacy and safety of Wilate, a new generation von Willebrand factor\/factor VIII concentrate","volume":"15","author":"Berntorp","year":"2009","journal-title":"Haemophilia"},{"issue":"3","key":"2022120916103203500_hem2022000390C8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1160\/TH13-11-0952","article-title":"Gastrointestinal angiodysplasia and bleeding in von Willebrand disease","volume":"112","author":"Franchini","year":"2014","journal-title":"Thromb Haemost"},{"issue":"4","key":"2022120916103203500_hem2022000390C9","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2012.04661.x","article-title":"Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patients","volume":"10","author":"Castaman","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2022120916103203500_hem2022000390C10","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1055\/s-0038-1649623","article-title":"International survey of patients with von Willebrand disease and angiodysplasia","volume":"70","author":"Fressinaud","year":"1993","journal-title":"Thromb Haemost"},{"issue":"9","key":"2022120916103203500_hem2022000390C11","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1111\/jth.15410","article-title":"Vascular abnormalities in patients with von Willebrand disease: a scoping review","volume":"19","author":"Chornenki","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2022120916103203500_hem2022000390C12","first-page":"981","article-title":"Capillary microscopic and rheological dimensions for the diagnosis of von Willebrand disease in comparison to other haemorrhagic diatheses","volume":"84","author":"Koscielny","year":"2000","journal-title":"Thromb Haemost"},{"issue":"14","key":"2022120916103203500_hem2022000390C13","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2012-06-435727","article-title":"Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells","volume":"121","author":"Starke","year":"2013","journal-title":"Blood"},{"issue":"3","key":"2022120916103203500_hem2022000390C14","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2010-01-264507","article-title":"Endothelial von Willebrand factor regulates angiogenesis","volume":"117","author":"Starke","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2022120916103203500_hem2022000390C15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jth.13551","article-title":"Von Willebrand factor and angiogenesis: basic and applied issues","volume":"15","author":"Randi","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2022120916103203500_hem2022000390C16","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/emboj\/18.4.882","article-title":"Role of \u03b1v\u03b23 integrin in the activation of vascular endothelial growth factor receptor-2","volume":"18","author":"Soldi","year":"1999","journal-title":"EMBO J"},{"issue":"1","key":"2022120916103203500_hem2022000390C17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0102-27","article-title":"Enhanced pathological angiogenesis in mice lacking \u03b23 integrin or \u03b23 and \u03b25 integrins","volume":"8","author":"Reynolds","year":"2002","journal-title":"Nat Med"},{"issue":"3","key":"2022120916103203500_hem2022000390C18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cellsig.2009.11.007","article-title":"Effects of angiopoietins-1 and -2 on the receptor tyrosine kinase Tie2 are differentially regulated at the endothelial cell surface","volume":"22","author":"Hansen","year":"2010","journal-title":"Cell Signal"},{"issue":"11","key":"2022120916103203500_hem2022000390C19","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood-2003-10-3685","article-title":"The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies","volume":"103","author":"Fiedler","year":"2004","journal-title":"Blood"},{"issue":"31","key":"2022120916103203500_hem2022000390C20","doi-asserted-by":"crossref","first-page":"23842","DOI":"10.1074\/jbc.M109.097543","article-title":"Angiopoietin-2 stimulation of endothelial cells induces alphavbeta3 integrin internalization and degradation","volume":"285","author":"Thomas","year":"2010","journal-title":"J Biol Chem"},{"issue":"6","key":"2022120916103203500_hem2022000390C21","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1055\/s-0037-1599145","article-title":"Angiodysplasia in von Willebrand disease: understanding the clinical and basic science","volume":"43","author":"Selvam","year":"2017","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"2022120916103203500_hem2022000390C22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.30802\/AALAS-CM-19-000003","article-title":"Characterization of a porcine model for von Willebrand disease type 1 and 3 regarding expression of angiogenic mediators in the nonpregnant female reproductive tract","volume":"69","author":"Allerkamp","year":"2019","journal-title":"Comp Med"},{"issue":"June","key":"2022120916103203500_hem2022000390C23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.thromres.2019.04.017","article-title":"von Willebrand disease and gastrointestinal bleeding: a national inpatient sample study","volume":"178","author":"Tsagianni","year":"2019","journal-title":"Thromb Res"},{"issue":"3","key":"2022120916103203500_hem2022000390C24","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/hae.12571","article-title":"The natural history of occult or angiodysplastic gastrointestinal bleeding in von Willebrand disease","volume":"21","author":"Makris","year":"2015","journal-title":"Haemophilia"},{"issue":"suppl 1","key":"2022120916103203500_hem2022000390C25","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.thromres.2006.01.022","article-title":"Gastrointestinal bleeding in von Willebrand disease","volume":"118","author":"Makris","year":"2006","journal-title":"Thromb Res"},{"issue":"4","key":"2022120916103203500_hem2022000390C26","first-page":"564","article-title":"Prevalence and natural history of colonic angiodysplasia among healthy asymptomatic people","volume":"90","author":"Foutch","year":"1995","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"2022120916103203500_hem2022000390C27","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1053\/gast.2001.21204","article-title":"Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract","volume":"120","author":"Veyradier","year":"2001","journal-title":"Gastroenterology"},{"issue":"4","key":"2022120916103203500_hem2022000390C28","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/gastro\/gou025","article-title":"Small bowel bleeding: a comprehensive review","volume":"2","author":"Gunjan","year":"2014","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"2","key":"2022120916103203500_hem2022000390C29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/jth.15155","article-title":"Gastrointestinal bleeding from angiodysplasia in von Willebrand disease: improved diagnosis and outcome prediction using videocapsule on top of conventional endoscopy","volume":"19","author":"Rauch","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2022120916103203500_hem2022000390C30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.giec.2006.11.001","article-title":"Complications of capsule endoscopy","volume":"17","author":"Ho","year":"2007","journal-title":"Gastrointest Endosc Clin N Am"},{"issue":"5","key":"2022120916103203500_hem2022000390C31","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/gutjnl-2018-317807","article-title":"Diagnosis and management of acute lower gastrointestinal bleeding: guidelines from the British Society of Gastroenterology","volume":"68","author":"Oakland","year":"2019","journal-title":"Gut"},{"issue":"11","key":"2022120916103203500_hem2022000390C32","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/M19-1795","article-title":"Management of nonvariceal upper gastrointestinal bleeding: guideline recommendations from the International Consensus Group","volume":"171","author":"Barkun","year":"2019","journal-title":"Ann Intern Med"},{"issue":"7","key":"2022120916103203500_hem2022000390C33","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/MBC.0000000000000632","article-title":"Recombinant von Willebrand factor for severe gastrointestinal bleeding unresponsive to other treatments in a patient with type 2A von Willebrand disease: a case report","volume":"28","author":"Brown","year":"2017","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"10241","key":"2022120916103203500_hem2022000390C34","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(20)30848-5","article-title":"Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial","volume":"395","author":"Roberts","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"2022120916103203500_hem2022000390C35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00001721-200103000-00009","article-title":"The management of von Willebrand's disease-associated gastrointestinal angiodysplasia","volume":"12","author":"Morris","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"5","key":"2022120916103203500_hem2022000390C36","doi-asserted-by":"crossref","first-page":"e12546","DOI":"10.1002\/rth2.12546","article-title":"Tranexamic acid evidence and controversies: an illustrated review","volume":"5","author":"Relke","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"2022120916103203500_hem2022000390C37","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2516.2012.02916.x","article-title":"Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN)","volume":"19","author":"Abshire","year":"2013","journal-title":"Haemophilia"},{"issue":"9","key":"2022120916103203500_hem2022000390C38","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/jth.12995","article-title":"Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis Network","volume":"13","author":"Abshire","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2022120916103203500_hem2022000390C39","first-page":"391","article-title":"A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF\/FVIII concentrates in severe inherited von Willebrand disease","volume":"17","author":"Peyvandi","year":"2019","journal-title":"Blood Transfus"},{"issue":"6","key":"2022120916103203500_hem2022000390C40","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1538-7836.2007.02562.x","article-title":"Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin): a prospective study of 50 patients","volume":"5","author":"Borel-Derlon","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2022120916103203500_hem2022000390C41","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/hae.13473","article-title":"Bleeding-related hospitalization in patients with von Willebrand disease and the impact of prophylaxis: results from national registers in Sweden compared with normal controls and participants in the von Willebrand Disease Prophylaxis Network","volume":"24","author":"Holm","year":"2018","journal-title":"Haemophilia"},{"issue":"2","key":"2022120916103203500_hem2022000390C42","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/hae.13419","article-title":"Lenalidomide as a novel therapy for gastrointestinal angiodysplasia in von Willebrand disease","volume":"24","author":"Khatri","year":"2018","journal-title":"Haemophilia"},{"issue":"10","key":"2022120916103203500_hem2022000390C43","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1182\/blood.2019003702","article-title":"How I treat gastrointestinal bleeding in congenital and acquired von Willebrand disease","volume":"136","author":"Biguzzi","year":"2020","journal-title":"Blood"},{"issue":"5","key":"2022120916103203500_hem2022000390C44","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1111\/hae.12196","article-title":"Tamoxifen for recurrent bleeds due to angiodysplasia in von Willebrand's disease","volume":"19","author":"Thachil","year":"2013","journal-title":"Haemophilia"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2022\/1\/624\/2021991\/624chornenki.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2022\/1\/624\/2021991\/624chornenki.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T16:14:52Z","timestamp":1670602492000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2022\/1\/624\/493472\/Special-considerations-in-GI-bleeding-in-VWD"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12,9]]},"published-print":{"date-parts":[[2022,12,9]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2022000390","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,9]]},"published":{"date-parts":[[2022,12,9]]}}}